The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/Ib study of afatinib with capecitabine in patients with refractory solid tumors and pancreaticobiliary cancers.
 
Gentry King
Consulting or Advisory Role - AstraZeneca; Ipsen
 
Kelsey Baker
No Relationships to Disclose
 
Andrew Coveler
Consulting or Advisory Role - Abbvie; Halozyme; Merrimack; Seagen
Research Funding - AbGenomics International (Inst); Actuate Therapeutics (Inst); Amgen (Inst); Amgen (Inst); AstraZeneca (Inst); Genentech (Inst); Gilead Sciences (Inst); Halozyme (Inst); Immunomedics (Inst); Lilly (Inst); Newlink Genetics (Inst); Nextrast (Inst); Novocure (Inst); Nucana (Inst); Onconova Therapeutics (Inst); Seagen (Inst); Surface Oncology (Inst); Taiho Pharmaceutical (Inst); XBiotech (Inst)
Travel, Accommodations, Expenses - Abbvie; Halozyme; Nucana
 
Rachael Safyan
Honoraria - Curio Science
Consulting or Advisory Role - Agenus; Guardant Health; Ipsen; Mirati Therapeutics
Research Funding - Exelixis (Inst); Replimune (Inst); Verastem (Inst)
 
Kit Wong
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Veena Shankaran
Honoraria - Cambia Health Foundation
Research Funding - Amgen (Inst); Apexigen (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck (Inst)
 
David Zhen
Consulting or Advisory Role - Boehringer Ingelheim; Bristol Myers Squibb; Exelixis; Jazz Pharmaceuticals; Legend Biotech; Medigene
Research Funding - A2 Biotherapeutics (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol Myers Squibb (Inst); Cornerstone Pharmaceuticals (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Genentech (Inst); Legend Biotech (Inst); Lilly (Inst); Medigene (Inst); Merck (Inst); Pfizer (Inst)
 
Hannah Lee
No Relationships to Disclose
 
Jeniece Hensel
No Relationships to Disclose
 
Reina Hibbert
No Relationships to Disclose
 
Greg Durm
Employment - Cook Biotech
Honoraria - AstraZeneca; Curio Science; Dava Oncology
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Mirati Therapeutics (Inst)
 
Mary Redman
No Relationships to Disclose
 
Colin Pritchard
Consulting or Advisory Role - Sana Biotechnology
Research Funding - Color Genomics (I)
 
Safi Shahda
Employment - Intellia Therapeutics
Stock and Other Ownership Interests - Intellia Therapeutics
 
E. Gabriela Chiorean
Consulting or Advisory Role - AADi; Astellas Pharma; BPGbio; Bristol-Myers Squibb/Celgene; IgM Biosciences; Ipsen; Merus; Pfizer; Purple Biotech; Regeneron; Takeda
Research Funding - Affini-T Therapeutics (Inst); BioAtla; Boehringer Ingelheim (Inst); Erasca, Inc (Inst); FibroGen (Inst); Genentech (Inst); Gilead/Forty Seven (Inst); Lonza (Inst); Merck (Inst); Mirati Therapeutics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Merus